Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
NCT Number: NCT04306874
Study investigators aim to assess the effect of providing high-protein nutritional supplementation before and after surgery
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19107, United States
Pancreaticoduodenectomy (PD) is a complex and morbid operation that is associated with many potential complications. Many people undergoing PD are malnourished due to their underlying medical condition or difficulties eating in the face of abdominal pain or obstruction from pancreatic disease. This study aims to assess the effect of high-protein dietary supplementation in improving perioperative nutrition and decreasing complications. We will randomize PD patients to an experimental arm in which they take a nutritional, high-protein supplement for 2 weeks before and after surgery, or to a control arm, where they will take a standard postoperative diet without supplementation. Outcomes and nutritional parameters will be examined after they complete the supplements.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Liquid shake with 30 g protein per serving
Time frame: 30 days
All complications within 30 days of surgery
Time frame: 6 months
Overall survival time since surgery
Time frame: 30 days
Serum prealbumin level (normal 15-36 mg/dL). Lower levels indicate acute malnutrition.
Thomas Jefferson University
Other
High-Protein Oral Nutritional Supplementation in Patients Undergoing Pancreaticoduodenectomy
Acronym: WPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02626195
Biliary Cancer, Biliary Tract Diseases
Goyang-si, Gyeonggi-do, South Korea
View Trial DetailsNCT01947166
Digestive System Diseases, Digestive System Neoplasms
Durham, North Carolina, United States
View Trial DetailsNCT06069297
Digestive System Diseases, Digestive System Neoplasms
Milan, Lombardy, Italy
View Trial DetailsNCT04846985
Body Weight, Body Weight Changes
Hillerød, Region Sjælland, Denmark
View Trial Details